Sphingomyelin synthase overexpression increases cholesterol accumulation and decreases cholesterol secretion in liver cells

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Yan, Nianlong ^a   Ding, Tingbo ^a   Dong, Jibin ^a   Li, Yue ^a   Wu, Manping ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; SPHINGOMYELIN; SPHINGOMYELIN SYNTHASE; SPHINGOMYELIN SYNTHASE 1; SPHINGOMYELIN SYNTHASE 2; SYNTHETASE; UNCLASSIFIED DRUG; PHOSPHATIDYLCHOLINE CERAMIDE PHOSPHOCHOLINE TRANSFERASE; PHOSPHATIDYLCHOLINE-CERAMIDE PHOSPHOCHOLINE TRANSFERASE; PHOSPHOTRANSFERASE;

ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CELL LINE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; GENE OVEREXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; BIOSYNTHESIS; CELL MEMBRANE; LIVER; METABOLISM; SECRETION; TUMOR CELL LINE;

APOLIPOPROTEIN A-I; CELL LINE, TUMOR; CHOLESTEROL; HUMANS; LIVER; MEMBRANE MICRODOMAINS; SPHINGOMYELINS; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

EID: 79953101275     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-46     Document Type: Article

References (33)

1. Williams KJ, Tabas I: The response-to-retention hypothesis of early atherogenesis. Arteriosc Thromb Vasc Biol 1995, 15(5):551-561.
2. Gordon DJ , Rifkind BM: High-density lipoprotein: the clinical implications of recent studies. N Engl J Med 1989, 321:1311-1316. (Pubitemid 19267219)
3. Lewis GF, Rader DJ: New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005, 96:1221-1232. (Pubitemid 40962099)
4. Rader DJ: High-density lipoproteins and atherosclerosis. Am J Cardiol 2002, 90:62-70.
5. Segrest JP, Jones MK, De Loof H, Brouillette CG, Venkatachalapathi YV, Anantharamaiah GM: The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res 1992, 33:141-166.
6. Curtiss LK, Volenta DT, Hime NJ, Rye KA: What is so special about apolipoprotein AI in reverse cholesterol transport? Arteriosc Thromb Vasc Biol 2006, 26:12-19.
7. Meyers CD, Kashyap ML: Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and ASprotection. Curr Opin Cardiol 2004, 19:366-373. (Pubitemid 38916496)
8. Simons K, Ikonen E: Functional rafts in cell membranes. Nature 1997, 387:569-572. (Pubitemid 27248754)
9. Subbaiah PV, Gesquiere LR, Wang K: Regulation of the selective uptake of cholesteryl esters from high density lipoproteins by sphingomyelin. J Lipid Res 2005, 46:2699-2705. (Pubitemid 43107482)
10. Jessup W, Gelissen IC, Gaus K, Kritharides L: Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr Opin Lipidol 2006, 17:247-257. (Pubitemid 43786058)
11. Fitzgerald ML, Mujawar Z, Tamehiro N: ABC transporters, ASand inflammation. Atherosclerosis 2010, 211:361-370.
12. Nilsson A, Duan RD: Absorption and lipoprotein transport of sphingomyelin. J Lipid Res 2006, 47:154-171. (Pubitemid 43107459)
13. Schlitt A, Blankenberg S, Yan D, Von Gizycki H, Buerke M, Werdan K, Bickel C, Lackner KJ, Meyer J, Rupprecht HJ, Jiang XC: Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease. Nutr Metab 2006, 3:5-12.
14. Park TS, Panek RL, Rekhter MD, Mueller SB, Rosebury WS, Robertson A, Hanselman JC, Kindt E, Homan R, Karathanasis SK: Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice. Atherosclerosis 2006, 189:264-272. (Pubitemid 44634484)
15. Hojjati MR, Li Z, Zhou H, Tang S, Huan C, Ooi E, Lu S, Jiang XC: Effect of myriocin on plasma sphingolipid metabolism and ASin apoE-deficient mice. J Biol Chem 2005, 280:10284-10289. (Pubitemid 40395884)
16. Park TS, Panek RL, Mueller SB, Hanselman JC , Rosebury WS , Robertson AW, Kindt EK, Homan R, Karathanasis SK , Rekhter MD: Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein Eknockout mice. Circulation 2004, 110:3465-3471. (Pubitemid 39602225)
17. Futerman AH , Stieger B, Hubbard AL , Pagano RE: Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus. J Biol Chem 1990, 265:8650-8657.
18. Huitema K, van den Dikkenberg J, Brouwers JF, Holthuis JC: Identification of a family of animal sphingomyelin synthases. EMBO J 2004, 23:33-44. (Pubitemid 38165745)
19. Ding TB, Li ZQ , Hailemariam T, Mukherjee S, Maxfield FR, Wu MP, Jiang XC: SMS overexpression and knockdown: impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis. J Lipid Res 2008, 49:376-385. (Pubitemid 351213622)
20. Dong JB, Wu MP, Jiang XC: Adenovirus-mediated overexpression of sphingomyelin synthase 1 and 2 increases the atherogenic potential in mice. J Lipid Res 2006, 47:1307-1314.
21. Meng AC, Luberto C, Bai A, Yang X, Hannun YA , Zhou D: Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells. Exp Cell Res 2004, 292:385-392. (Pubitemid 38018853)
22. Liu J, Huan C, Chakraborty M, Zhang H, Lu D, Kuo MS, Cao G, Jiang XC: Macrophage sphingomyelin synthase 2 deficiency decreases ASin mice. Circ Res 2009, 105:295-303.
23. Jin FY, Kamanna VS, Kashyap ML: Niacin decreases removal of high density lipoprotein A-I but not cholesterol ester by HepG2 cells. Arteriosc Thromb Vasc Biol 1997, 17:2020-2028.
24. Ishitsuka R, Yamaji-Hasegawa A, Makino A, Hirabayashi Y, Kobayashi T: A lipid-specific toxin reveals heterogeneity of sphingomyelin-containing membranes. Biophys J 2004, 86:296-307. (Pubitemid 38067457)
25. Ito JI, Nagayasu Y , Yokoyamal S: Cholesterol-sphingomyelin interaction in membrane and apolipoprotein-mediated cellular cholesterol efflux. J Lipid Res 2000, 41:894-904. (Pubitemid 30434320)
26. Simons K, Ehehalt R: Cholesterol, lipid rafts, and disease. J Clin Invest 2002, 110:597-603. (Pubitemid 34988781)
27. Li Z, Hailemariam TK, Zhou H, Li Y, Duckworth DC, Peake DA, Zhang Y, Kuo MS, Cao G, Jiang XC: Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization. Biochimica et Biophysica Acta 2007, 1771:1186-1194. (Pubitemid 47404966)
28. Prinetti A, Chigorno V, Prioni S, Loberto N, Marano N, Tettamanti G, Sonnino S: Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro. J Biol Chem 2001, 276:21136-21145.
29. Brown DA, London E: Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 2000, 275:17221-17224. (Pubitemid 30430750)
30. Keller P, Simons K: Cholesterol is required for surface transport of influenza virus hemagglutinin. J Cell Biol 1998, 140:1357-1367. (Pubitemid 28152985)
31. Brown RE: Sphingolipid organization in biomembranes: what physical studies of model membranes reveal. J Cell Sci 1998, 111:1-9.
32. Lee CY, Lesimple A, Denis M, Vincent J, Larsen A, Mamer O, Krimbou L, Genest J, Marcil M: Increased sphingomyelin content impairs HDL biogenesis and maturation in human Niemann-Pick disease type B. J Lipid Res 2006, 47:622-632. (Pubitemid 43345603)
33. Ouimet M, Wang MD, Cadotte N, Ho K, Marcel YL: Epoxycholesterol Impairs Cholesteryl Ester Hydrolysis in Macrophage Foam Cells, Resulting in Decreased Cholesterol Efflux. Arteriosc Thromb Vasc Biol 2008, 28:1144-1150.